Home | News | Find a Doctor | Ask a Question | Free

More EGRF inhibition evidence


#1

Abnormal Hair Growth in a Patient With Head and Neck Cancer Treated With the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab

http://jco.ascopubs.org/cgi/content/full/23/22/5273

But it can work even the other way around:

Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib

http://linkinghub.elsevier.com/retrieve/pii/S0190962205047444